Business Standard

Sandu Pharmaceuticals net profit declines 47.62% in the June 2013 quarter

Image

Capital Market

Sales rise 18.49% to Rs 8.46 crore

Net profit of Sandu Pharmaceuticals declined 47.62% to Rs 0.11 crore in the quarter ended June 2013 as against Rs 0.21 crore during the previous quarter ended June 2012. Sales rose 18.49% to Rs 8.46 crore in the quarter ended June 2013 as against Rs 7.14 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales8.467.14 18 OPM %6.037.00 -PBDT0.330.37 -11 PBT0.140.26 -46 NP0.110.21 -48

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 17 2013 | 8:27 AM IST

Explore News